News

Article

22 Dec 2020

Medicines Development for Global Health Receives FDA Orphan Drug Designation for Dovramilast to Treat Leprosy Type 2 Reaction

November 3, 2023

Article

22 Dec 2020

American Society for Tropical Medicine and Hygiene Annual Meeting

October 20, 2023

Article

22 Dec 2020

Medicines Development for Global Health is a founding member of the Clinical Trials Community Africa Network

October 19, 2023

Article

22 Dec 2020

New modelling study suggests potential for moxidectin to accelerate elimination of river blindness in Africa

October 19, 2023

Article

22 Dec 2020

Phase 3b/4 study comparing moxidectin with ivermectin in river blindness is fully enrolled

October 19, 2023

Article

22 Dec 2020

Podcast interview with Mark Sullivan

August 9, 2023

Article

22 Dec 2020

For moxidectin, FDA approval for river blindness was just the beginning

August 2, 2023

Article

22 Dec 2020

Medicines Development for Global Health joins the WHO's Global Accelerator for Paediatric Formulations (GAP-f) Network

August 2, 2023

Article

22 Dec 2020

Medicines Development for Global Health is a signatory of the Nagasaki Statement

August 2, 2023

Article

22 Dec 2020

Medicines Development for Global Health announces new head of Philanthropy

August 2, 2023

Article

22 Dec 2020

‍Medicines Development for Global Health opens a new study site in Côte D’Ivoire

May 16, 2023

Article

22 Dec 2020

Medicines Development for Global Health receives US$4.9M grant for moxidectin programs

December 22, 2022

Article

22 Dec 2020

Welcome to the newest members of the team

December 21, 2022

Article

22 Dec 2020

Moxidectin for river blindness: clinical study updates

December 21, 2022

Article

22 Dec 2020

Moxidectin for scabies: clinical study updates

December 21, 2022

Article

22 Dec 2020

‍UK and US Offices receive Charity status

December 21, 2022

Article

22 Dec 2020

American Society of Tropical Medicine and Hygiene Annual Meeting

December 21, 2022

Article

22 Dec 2020

American Society of Tropical Medicine and Hygiene Annual Meeting

October 11, 2022

Article

22 Dec 2020

Learn about our latest Annual Report, attendance at ASTMH annual meeting, signing of the Kigali Declaration, job opportunities and more.

MDGH Update - October 2022

October 1, 2022

Article

22 Dec 2020

2021 Annual Report Published

August 12, 2022

No results found

Please try again.

Article

Medicines Development for Global Health Receives FDA Orphan Drug Designation for Dovramilast to Treat Leprosy Type 2 Reaction

Article

American Society for Tropical Medicine and Hygiene Annual Meeting

Article

Medicines Development for Global Health is a founding member of the Clinical Trials Community Africa Network

Article

New modelling study suggests potential for moxidectin to accelerate elimination of river blindness in Africa

Article

Phase 3b/4 study comparing moxidectin with ivermectin in river blindness is fully enrolled

Article

Podcast interview with Mark Sullivan

Article

For moxidectin, FDA approval for river blindness was just the beginning

Article

Medicines Development for Global Health joins the WHO's Global Accelerator for Paediatric Formulations (GAP-f) Network

Article

Medicines Development for Global Health is a signatory of the Nagasaki Statement

Article

Medicines Development for Global Health announces new head of Philanthropy

Article

‍Medicines Development for Global Health opens a new study site in Côte D’Ivoire

Article

Medicines Development for Global Health receives US$4.9M grant for moxidectin programs

Article

Welcome to the newest members of the team

Article

Moxidectin for river blindness: clinical study updates

Article

Moxidectin for scabies: clinical study updates

Article

‍UK and US Offices receive Charity status

Article

American Society of Tropical Medicine and Hygiene Annual Meeting

Article

American Society of Tropical Medicine and Hygiene Annual Meeting

Article

MDGH Update - October 2022

Article

2021 Annual Report Published

No results found

Media kit

Stay up to date